Search results
Results from the WOW.Com Content Network
The Rheumatoid Arthritis Severity Scale (RASS) is based on sections of the ACR scoring system. [3] The 2010 ACR / EULAR Rheumatoid Arthritis Classification Criteria, which includes anti-CCP testing, has been developed to focus on early disease, and on features that are associated with persistent or erosive disease. [4]
Anti-CCP is part of the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis. Anti-CCP positivity is also a good prognostic marker for future radiographic damage, and possibly a marker to B-cell therapy responses including rituximab. [24]
The aims of EULAR are to reduce the burden of rheumatic diseases on the individual and society and to improve the treatment, prevention and rehabilitation of musculoskeletal diseases. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with musculoskeletal diseases by the ...
These new classification criteria overruled the "old" ACR criteria of 1987 and are adapted for early RA diagnosis. The "new" classification criteria, jointly published by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) establish a point value between 0 and 10
Rheumatoid factor is part of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis. RF positivity combines well with anti-CCP and/or 14-3-3η to inform diagnosis. [9] RF positivity at baseline has also been described as a good prognostic marker for future radiographic damage. [10]
Aletaha is the author of more than 250 peer-reviewed publications, including in international journals such as The Lancet and Nature Medicine. [citation needed] He is first author of the international classification criteria for rheumatoid arthritis (ACR/EULAR 2010 Classification Criteria for Rheumatoid Arthritis).
In the context of rheumatoid arthritis (RA), CRP is one of the acute phase reactants, whose assessment is defined as part of the joint 2010 ACR/EULAR classification criteria for RA with abnormal levels accounting for a single point within the criteria.
More recent classifications, the 2006 European League Against Rheumatism (EULAR) and Pediatric Rheumatology Society (PReS) classification, include palpable purpura as a mandatory criterion, together with at least one of the following findings: diffuse abdominal pain, predominant IgA deposition (confirmed on skin biopsy), acute arthritis in any ...